An intelligent DNA nanodevice for precision thrombus therapy  

作　　者：Yihao Zhou Qiangbin Wang 

机构地区：[1]CAS Key Laboratory of Nano-Bio Interface,Division of Nanobiomedicine and i-Lab,Suzhou Instiute of Nano-Tech and Nano-Bionics,Chinese Academy of Sciences,Suzhou 215123,China

出　　处：《Science China Chemistry》2024年第10期3195-3197,共3页中国科学（化学英文版）

摘　　要：Obstruction of blood vessels(thrombosis)due to blood clots is one of the main causes of death worldwide and is associated with many cardiovascular diseases,such as myocardial infarction,ischemic stroke,and pulmonary embolism[1].Thrombolytic therapy is currently the preferred treatment for acute thrombosis and is administered intravenously with thrombolytic drugs,such as tissue plasminogen activator(tPA)[2].

关 键 词：DRUGS CARDIOVASCULAR ACUTE 

分 类 号：TB383.1[一般工业技术—材料科学与工程] R318.6[医药卫生—生物医学工程]